HGH 191AA, also known as Somatropin, is a recombinant form of human growth hormone comprising the full 191 amino acid sequence identical to endogenous pituitary-derived GH. As a research compound, it has been extensively studied for its involvement in the regulation of cell proliferation, lipid metabolism, protein synthesis, and IGF-1 stimulation via hepatic pathways.
In preclinical research settings, Somatropin has been investigated for its potential roles in body composition modulation, bone density studies, muscle tissue research, and metabolic dysfunction models. It acts by binding to GH receptors on target cells, triggering the JAK-STAT signalling cascade and downstream IGF-1 production, making it a valuable tool in endocrinological and metabolic research.
This 35mg vial of HGH 191AA is supplied as a lyophilised powder with a purity of greater than 98%, as verified by HPLC analysis. The molecular formula is C₉₉₀H₁₅₂₉N₂₆₃O₃₀₂S₇, with a molecular weight of approximately 22,124 g/mol. CAS number: 12629-01-5.
For optimal stability, the lyophilised product should be stored at -20°C and protected from light and moisture. Once reconstituted, it should be kept at 2–8°C and used within a short period.
Molecular Formula
C₉₉₀H₁₅₂₉N₂₆₃O₃₀₂S₇
Molecular Weight
22,124 g/mol
Purity
>98%
CAS Number
12629-01-5
Form
Lyophilised Powder
Research Applications
Endocrinology research, Metabolic dysfunction models, Body composition studies, Bone density research, IGF-1 pathway investigation, Cellular proliferation studies
For research purposes only. Not for human use.
Reviews
There are no reviews yet.